Capital International Sarl Hutchmed (China) LTD Transaction History

Capital International Sarl

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$8.59 - $20.77 $983,383 - $2.38 Million	-114,480 Reduced 17.37%	544,653 $6.88 Million
Q1 2022 May 16, 2022	BUY	$15.52 - $35.65 $475,781 - $1.09 Million	30,656 Added 4.88%	659,133 $12.5 Million
Q3 2021 Nov 15, 2021	BUY	$35.66 - $42.94 $2.88 Million - $3.47 Million	80,734 Added 14.74%	628,477 $23 Million
Q1 2021 May 14, 2021	SELL	$27.01 - $36.8 $614,666 - $837,457	-22,757 Reduced 3.99%	547,743 $15.5 Million
Q4 2020 Feb 16, 2021	SELL	$27.51 - $34.36 $173,808 - $217,086	-6,318 Reduced 1.1%	570,500 $18.3 Million
Q3 2020 Nov 16, 2020	SELL	$25.8 - $34.61 $585,918 - $785,993	-22,710 Reduced 3.79%	576,818 $18.6 Million
Q2 2020 Aug 14, 2020	SELL	$17.65 - $28.05 $834,209 - $1.33 Million	-47,264 Reduced 7.31%	599,528 $16.5 Million
Q1 2020 May 15, 2020	BUY	$15.19 - $29.51 $697,221 - $1.35 Million	45,900 Added 7.64%	646,792 $11.5 Million
Q4 2019 Feb 18, 2020	SELL	$17.17 - $25.95 $3.65 Million - $5.51 Million	-212,500 Reduced 26.13%	600,892 $15.1 Million
Q3 2019 Nov 14, 2019	BUY	$17.84 - $22.69 $931,622 - $1.18 Million	52,221 Added 6.86%	813,392 $14.5 Million
Q2 2019 Aug 14, 2019	BUY	$22.0 - $31.78 $4.04 Million - $5.83 Million	183,416 Added 31.75%	761,171 $16.7 Million
Q1 2019 May 15, 2019	BUY	$21.27 - $30.58 $12.3 Million - $17.7 Million	577,755 New	577,755 $17.7 Million

8.25M

3.8K

2.4K

Ticker HCM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 172,955,008
Market Cap $3.11B
Description
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...

Get notified when there are updates to the investment portfolio of Capital International Sarl, based on Form 13F filings with the SEC.

Stay updated on Capital International Sarl with notifications on news.